Literature DB >> 22998476

Treatment of BRAF inhibitor-induced hyperkeratosis.

Jodie E Battley, Elizabeth Lenihan, Henry P Redmond, Michelle Murphy, Derek G Power.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22998476     DOI： 10.3109/0284186X.2012.716165

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  2 in total

1.  Targeted Therapies Compared to Dacarbazine for Treatment of BRAF(V600E) Metastatic Melanoma: A Cost-Effectiveness Analysis.

Authors:  Vanessa Shih; Renske M Ten Ham; Christine T Bui; Dan N Tran; Jie Ting; Leslie Wilson
Journal:  J Skin Cancer       Date:  2015-06-10

2.  Tegumentary manifestations of Noonan and Noonan-related syndromes.

Authors:  Caio Robledo D'Angioli Costa Quaio; Tatiana Ferreira de Almeida; Amanda Salem Brasil; Alexandre C Pereira; Alexander A L Jorge; Alexsandra C Malaquias; Chong Ae Kim; Débora Romeo Bertola
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.